cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Ptc Therapeutics Inc
1 own
8 watching
Current Price
$46.23
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
3,321.85M
52-Week High
52-Week High
55.5799
52-Week Low
52-Week Low
25.01
Average Volume
Average Volume
0.51M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization3,321.85M
icon52-Week High55.5799
icon52-Week Low25.01
iconAverage Volume0.51M
iconDividend Yield--
iconP/E Ratio--
What does the Ptc Therapeutics Inc do?
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered, small molecule drugs that target post-transcriptional control processes. The company's lead product is Translarna (ataluren), for the treatment of nonsense mutation Duchenne muscular dystrophy in ambulatory patients; and which is in phase III clinical trials to treat cystic fibrosis caused by nonsense mutations. It also develops Translarna, which is in Phase II clinical trials for the treatment of mucopolysaccharidosis type I caused by nonsense mutation, nonsense mutation aniridia, and nonsense mutation Dravet syndrome/CDKL5; and RG7916 that is in Phase I clinical trials to treat spinal muscular atrophy. In addition, the company's product candidate in cancer stem cell program include PTC596, an orally bioavailable and potent small molecule, which has completed phase I clinical trials that targets tumor stem cell populations by reducing the activity and amount of a protein called BMI1. PTC Therapeutics, Inc. has collaborations with F. Hoffman-La Roche Ltd and Hoffman-La Roche Inc., and the Spinal Muscular Atrophy Foundation to develop and commercialize compounds identified under its spinal muscular atrophy sponsored research program; and research collaboration with Massachusetts General Hospital for the treatment of rare genetic disorders resulting from pre-mRNA. The company was founded in 1998 and is headquartered in South Plainfield, New Jersey.
Read More
How much money does Ptc Therapeutics Inc make?
News & Events about Ptc Therapeutics Inc.
PR Newswire
5days ago
PTC Therapeutics Receives 2023 EURORDIS Black Pearl Company Award for Innovation PTC Therapeutics Receives 2023 EURORDIS Black Pearl Company Award for Innovation PR Newswire SOUTH PLAINFIELD, N.J., Feb. 3, 2023 - This award recognizes PTC's 25-year legacy in discovering and delivering novel...
PR Newswire
30days ago
PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 41st Annual J.P. Morgan Healthcare Conference PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 41st Annual J.P. Morgan Healthcare Conference PR Newswire SOUTH PLAINFIELD...
Ticker Report
1month ago
The Goldman Sachs Group started coverage on shares of PTC Therapeutics (NASDAQ:PTCT Get Rating) in a research report report published on Wednesday, The Fly reports. The firm issued a sell rating and a $35.00 price target on the biopharmaceutical companys stock. A number of other ...
Globe Newswire
1month ago
NEW YORK, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating whether certain officers and directors of PTC Therapeutics, Inc. (NASDAQ: PTCT) breached their fiduciary duties to shareholders. The investigation concerns potential self-...
Frequently Asked Questions
Frequently Asked Questions
What is Ptc Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Ptc Therapeutics Inc shares?
plus_minus_icon
How can I buy Ptc Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Ptc Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Ptc Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Ptc Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Ptc Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Ptc Therapeutics Inc?
plus_minus_icon
What percentage is Ptc Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Ptc Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$46.23
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00